(NASDAQ: OMIC) Singular Genomics Systems's forecast annual revenue growth rate of 91.3% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 20.15%.
Singular Genomics Systems's revenue in 2025 is $2,666,000.On average, 1 Wall Street analysts forecast OMIC's revenue for 2025 to be $12,810,093, with the lowest OMIC revenue forecast at $12,810,093, and the highest OMIC revenue forecast at $12,810,093.
In 2026, OMIC is forecast to generate $40,942,063 in revenue, with the lowest revenue forecast at $40,942,063 and the highest revenue forecast at $40,942,063.